Anti-BK virus activity of nucleoside analogs

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1519-1521

  Randhawa, Parmjeet ^a,h   Zemlicka, Jiri ^b   Sauerbrei, Andreas ^c,d   Meier, Chris ^e   Hostetler, Karl Y ^f   Beadle, James R ^f   Farasati, Noush Afarin ^a   Huang, Yuchen ^a   Bradley, Matthews ^f,g  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Barbara Ann Karmanos Institute   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g Luitpold Pharmaceuticals   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; 9 [2 (PHOSPHONOMETHOXY)ETHYL]ADENINE; ACICLOVIR DERIVATIVE; ADEFOVIR; CIDOFOVIR; CYCLOPROPANE DERIVATIVE; CYCLOPROPAVIR; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DIDANOSINE; DIPIVOXIL; ESTER DERIVATIVE; FAMCICLOVIR; FATTY ACID DERIVATIVE; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; P 393; P 405; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; SYNADENOL; SYNGUANOL; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG; ZIDOVUDINE; ZSM I 32 F;

ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; IN VITRO STUDY; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ADENINE; BK VIRUS; ESTERS; FATTY ACIDS; HUMANS; MICROBIAL SENSITIVITY TESTS; NUCLEOSIDES; PHOSPHONIC ACIDS; VIRUS REPLICATION;

EID: 42049108190     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01241-07     Document Type: Article

References (28)

1. Andrei, G., R. Snoeck, M. Vandeputte, and E. De Clercq. 1997. Activities of various compounds against murine and primate polyomaviruses. Antimicrob. Agents Chemother. 41:587-593.
2. Baker, R., M. Bray, and J. W. Huggins. 2003. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antivir. Res. 57:13-23.
3. Balzarini, J., F. Haller-Meier, E. De Clercq, and C. Meier. 2001. Antiviral activity of cycloSaligenyl prodrugs of acyclovir, carbovir and abacavir. Antivir. Chem. Chemother. 12:301-306.
4. Beadle, J. R., K. Y. Hostetler, R. M. Buller, J. Schriewer, K. A. Aldern, M. N. Prichard, K. Keith, and E. R. Kern. 2007. Synthesis and antiviral evaluation of iso-methyl-alkoxyalkyl (S)-HPMPA esters. Antivir. Res. 74:A48.
5. Daugas, E., J. P. Rougier, and G. Hill. 2005. HAART-related nephropathies in HIV-infected patients. Kidney Int. 67:393-403.
6. Farasati, N. A., R. Shapiro, A. Vats, and P. Randhawa. 2005. Effect of leflunomide and cidofovir on replication of BK-virus in an in vitro culture system. Transplantation 79:116-118.
7. Fishman, J. A. 2002. BK virus nephropathy: Polyomavirus adding insult to injury. N. Engl. J. Med. 347:527-530.
8. Fung, J., C. Lai, J. Yuen, D. Wong, Y. Tanaka, M. Mizokami, and M. Yuen. 2007. Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population. Antivir. Ther. 12:41-46.
9. Hartline, C., K. Gustin, W. Wan, S. Ciesla, J. Beadle, K. Hostetler, and E. Kern. 2005. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J. Infect. Dis. 191:396-399.
10. Josephson, M. A., R. D. Poduval, P. V. Kadambi, B. Javaid, R. C. Harland, P. F. Foster, J. R. Thistlethwaite, S. M. Meehan, and J. W. Williams. 2003 BK nephropathy: can leflunomide control it? J. Am. Soc. Nephrol. 14:43A.
11. Lebeau, I., G. Andrei, M. Krecmerova, E. De Clercq, A. Holy, and R. Snoeck. 2007. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains. Antimicrob. Agents Chemother. 51:2268-2273.
12. Matthews, G. V., D. A. Cooper, and G. J. Dore. 2007. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. Antivir. Ther. 12:119-122.
13. Meier, C., L. Habel, F. Haller-Meier, A. Lomp, M. Herderich, R. Klocking, A. Meerbach, and P. Wutzler. 1998. Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues. Antivir. Chem. Chemother. 9:389-402.
14. Meier, C., T. Knispel, E. De Clercq, and J. Balzarini. 1999. cycloSal-pronucleotides of 2′,3′-dideoxyadenosine and 2′,3′-dideoxy-2′,3′-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system. J. Med. Chem. 42:1604-1614.
15. Meier, C., A. Lomp, A. Meerbach, and P. Wutzler. 2002. CycloSal-BVDUMP pronucleotides: how to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV. J. Med. Chem. 45:5157-5172.
16. Meier, C., A. Lomp, A. Meerbach, and P. Wutzler. 2001. Synthesis, hydrolysis and anti-EBV activity of a series of 3′-modified cycloSal-BVDUMP pronucleotides. Nucleosides Nucleotides Nucleic Acids 20:307-314.
17. Mentel, R., M. Kinder, U. Wegner, M. von Janta-Lipinski, and E. Matthes. 1997. Inhibitory activity of 3′-fluoro-2′ deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antivir. Res. 34:113-119.
18. Naesens, L., L. Lenaerts, G. Andrei, R. Snoeck, D. Van Beers, A. Holy, J. Balzarini, and E. De Clercq. 2005. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 49:1010-1016.
19. Randhawa, P., N. A. Farasati, R. Shapiro, and K. Y. Hostetler. 2006. Ether lipid ester derivatives of cidofovir inhibit Polyomavirus BK replication in vitro. Antimicrob. Agents Chemother. 50:1564-1566.
20. Randhawa, P. S., A. Vats, D. Zygmunt, P. A Swalsky, V. Scantlebury, R. Shapiro, and S. Finkelstein. 2002. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74:485-488.
21. Reymen, D., L. Naesens, J. Balzarini, A. Holy, H. Dvorakova, and E. DeClercq. 1995. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antivir. Res. 28:343-357.
22. Sauerbrei, A., C. Meier, A. Meerbach, and P. Wutzler. 2006. Inhibitory efficacy of cycloSal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxviruses. Antivir. Chem. Chemother. 17:25-31.
23. Scantlebury, V., R. Shapiro, P. S. Randhawa, K. Week, and A. Vats. 2002. Cidofovir: a method of treatment for BK virus associated transplant nephropathy. Graft 5(Suppl.):S82-S86.
24. Smee, D. F., B. B. Barnett, R. W. Sidwell, E. J. Reist, and A. Holy. 1995. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Antivir. Res. 26:1-9.
25. Vats, A., R. Shapiro, P. Singh Randhawa, V. Scantlebury, A. Tuzuner, M. Saxena, M. L. Moritz, T. J. Beattie, T. Gonwa, M. D. Green, and D. Ellis. 2003. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 75:105-112.
26. Wadei, H. M., A. D. Rule, M. Lewin, A. S. Mahale, H. A. Khamash, T. R. Schwab, J. M. Gloor, S. C. Textor, M. E. Fidler, D. J. Lager, T. S. Larson, M. D. Stegall, F. G. Cosio, and M. D. Griffin. 2006. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus- associated nephropathy (PVAN). Am. J. Transplant. 6:1025-1032.
27. Zemlicka, J., and X. Chen. 2004. Methylenecyclopropane analogs of nucleosides as antiviral agents, p. 267-307. In R. F. Schinazi and D. C. Liotta (ed.), Frontiers in nucleosides and nucleic acids. IHL Press, Tucker, GA.
28. Zhou, S. M., J. M. Breitenbach, K. Z. Borysko, J. C. Drach, E. R. Kern, E. Gullen, Y. C. Cheng, and J. Zemlicka. 2004. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. J. Med. Chem. 47:566-575.